84 related articles for article (PubMed ID: 7524660)
1. Characterization of a fluorescent substance P analog.
Tota MR; Daniel S; Sirotina A; Mazina KE; Fong TM; Longmore J; Strader CD
Biochemistry; 1994 Nov; 33(44):13079-86. PubMed ID: 7524660
[TBL] [Abstract][Full Text] [Related]
2. Characterization of non-peptide antagonist and peptide agonist binding sites of the NK1 receptor with fluorescent ligands.
Turcatti G; Zoffmann S; Lowe JA; Drozda SE; Chassaing G; Schwartz TW; Chollet A
J Biol Chem; 1997 Aug; 272(34):21167-75. PubMed ID: 9261122
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the binding of a potent, selective, radioiodinated antagonist to the human neurokinin-1 receptor.
Cascieri MA; Ber E; Fong TM; Sadowski S; Bansal A; Swain C; Seward E; Frances B; Burns D; Strader CD
Mol Pharmacol; 1992 Sep; 42(3):458-63. PubMed ID: 1383685
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the interaction of N-acyl-L-tryptophan benzyl ester neurokinin antagonists with the human neurokinin-1 receptor.
Cascieri MA; Macleod AM; Underwood D; Shiao LL; Ber E; Sadowski S; Yu H; Merchant KJ; Swain CJ; Strader CD
J Biol Chem; 1994 Mar; 269(9):6587-91. PubMed ID: 7509807
[TBL] [Abstract][Full Text] [Related]
5. Point mutation increases a form of the NK1 receptor with high affinity for neurokinin A and B and septide.
Ciucci A; Palma C; Manzini S; Werge TM
Br J Pharmacol; 1998 Sep; 125(2):393-401. PubMed ID: 9786514
[TBL] [Abstract][Full Text] [Related]
6. Radioiodinated substance P, neurokinin A, and eledoisin bind predominantly in NK1 receptors in guinea pig lung.
Geraghty DP; Mussap CJ; Burcher E
Mol Pharmacol; 1992 Jan; 41(1):147-53. PubMed ID: 1370705
[TBL] [Abstract][Full Text] [Related]
7. Gastric chief cells possess NK1 receptors which mediate pepsinogen secretion and are regulated by agents that increase cAMP and phospholipase C.
Kitsukawa Y; Turner RJ; Pradhan TK; Jensen RT
Biochim Biophys Acta; 1996 Jun; 1312(2):105-16. PubMed ID: 8672532
[TBL] [Abstract][Full Text] [Related]
8. Identification of both NK1 and NK2 receptors in guinea-pig airways.
McKee KT; Millar L; Rodger IW; Metters KM
Br J Pharmacol; 1993 Oct; 110(2):693-700. PubMed ID: 7694756
[TBL] [Abstract][Full Text] [Related]
9. Comparison of tachykinin NK1 and NK2 receptors in the circular muscle of the guinea-pig ileum and proximal colon.
Maggi CA; Patacchini R; Meini S; Quartara L; Sisto A; Potier E; Giuliani S; Giachetti A
Br J Pharmacol; 1994 May; 112(1):150-60. PubMed ID: 7518302
[TBL] [Abstract][Full Text] [Related]
10. Novel selective agonists and antagonists confirm neurokinin NK1 receptors in guinea-pig vas deferens.
Hall JM; Morton IK
Br J Pharmacol; 1991 Feb; 102(2):511-7. PubMed ID: 1707714
[TBL] [Abstract][Full Text] [Related]
11. Esmolol activates endogenous neurokinin activity inhibiting infarction-induced arrhythmias in rats: novel mechanisms of anti-arrhythmia.
Wang LL; Han Y; Guo Z; Han SQ; Liu T
Regul Pept; 2013 Sep; 186():116-22. PubMed ID: 23994276
[TBL] [Abstract][Full Text] [Related]
12. Interaction of substance P with the second and seventh transmembrane domains of the neurokinin-1 receptor.
Huang RR; Yu H; Strader CD; Fong TM
Biochemistry; 1994 Mar; 33(10):3007-13. PubMed ID: 7510519
[TBL] [Abstract][Full Text] [Related]
13. The pharmacology of GR203040, a novel, potent and selective non-peptide tachykinin NK1 receptor antagonist.
Beattie DT; Beresford IJ; Connor HE; Marshall FH; Hawcock AB; Hagan RM; Bowers J; Birch PJ; Ward P
Br J Pharmacol; 1995 Dec; 116(8):3149-57. PubMed ID: 8719789
[TBL] [Abstract][Full Text] [Related]
14. Receptors mediating tachykinin-evoked depolarisations of neurons in the neonatal rat spinal cord.
Fox AJ; Naeem S; Patel IA; Walpole C; Urbán L
Acta Biol Hung; 1996; 47(1-4):129-44. PubMed ID: 9123986
[TBL] [Abstract][Full Text] [Related]
15. Typical and atypical NK1 tachykinin receptor characteristics in the rabbit isolated iris sphincter.
Hall JM; Mitchell D; Morton IK
Br J Pharmacol; 1994 Jul; 112(3):985-91. PubMed ID: 7522864
[TBL] [Abstract][Full Text] [Related]
16. p-(4-Hydroxybenzoyl)phenylalanine: a photoreactive amino acid analog amenable to radioiodination for elucidation of peptide-protein interaction. Application to substance P receptor.
Wilson CJ; Husain SS; Stimson ER; Dangott LJ; Miller KW; Maggio JE
Biochemistry; 1997 Apr; 36(15):4542-51. PubMed ID: 9109663
[TBL] [Abstract][Full Text] [Related]
17. Development of a biotinylated analog of substance P for use as a receptor probe.
Anton PA; Reeve JR; Vidrich A; Mayer E; Shanahan F
Lab Invest; 1991 May; 64(5):703-8. PubMed ID: 1709427
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological in vitro evaluation of new substance P-cyclodextrin derivatives designed to drug targeting towards NK1-receptor bearing cells.
Péan C; Wijkhuisen A; Djedaïni-Pilard F; Fischer J; Doly S; Conrath M; Couraud JY; Grassi J; Perly B; Créminon C
Biochim Biophys Acta; 2001 Dec; 1541(3):150-60. PubMed ID: 11755209
[TBL] [Abstract][Full Text] [Related]
19. Effect of the tachykinin NK1 receptor antagonists, RP 67580 and SR 140333, on electrically-evoked substance P release from rat spinal cord.
Malcangio M; Bowery NG
Br J Pharmacol; 1994 Oct; 113(2):635-41. PubMed ID: 7530576
[TBL] [Abstract][Full Text] [Related]
20. Investigation of the effect of homocysteinylation of substance P on its binding to the NK1 receptor using molecular dynamics simulation.
Davoudmanesh S; Mosaabadi JM
J Mol Model; 2018 Jun; 24(7):177. PubMed ID: 29943287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
